Next, we subcutaneously injected control or DAPK1-overexpressing 786-O-R cells into nude mice to study the in vivo effects of DAPK1 overexpression on the growth of sunitinib-resistant ccRCC cells. Here, DAPK1 is linked to nonpapillary renal cell carcinoma.